CN1056283C

CN1056283C - Chinese medicine for curing aftereffect resulted from cerebral embolism

Info

Publication number: CN1056283C
Application number: CN94118274A
Authority: CN
Inventors: 赵克顺
Original assignee: Individual
Current assignee: Individual
Priority date: 1994-11-19
Filing date: 1994-11-19
Publication date: 2000-09-13
Anticipated expiration: 2014-11-19
Also published as: CN1123168A

Abstract

The present invention relates to a traditional Chinese medicine for treating sequela caused by a cerebral embolism, which is characterized in that the traditional Chinese medicine is composed of 20 to 25% of angelica, 10 to 15% of fleece-flower root, 10 to 15% of dodder, 15 to 25% of achyranthes root, 15 to 20% of malaytea scurfpea fruit and 10 to 15% of raspberry. The formula is prepared into a medicine which can be a pill or an oral solution. The medicine has the therapeutic effects and the advantages that blood activation and blood enriching medicines are repeatedly used by a product, and the traditional Chinese medicine has obvious therapeutic effect and rapid effect; the traditional Chinese medicine is suitable for various diseases, and the symptoms of brain contraction, hyperlipoidemia, etc. caused by all thrombi, and simultaneously has the efficacy of apoplexy prevention and aging resistance; the traditional Chinese medicine has no toxic side effect, low cost and convenient taking.

Description

A kind of Chinese medicine for the treatment of cerebral infarction sequela

The present invention is a kind of Chinese medicine for the treatment of cerebral infarction sequela, and being spreaded one's fame by numerous benefited patients is continuous life pellet.

At present, there is not specific drug for human cerebral embolism treatment of conditions, its treatment means is nothing more than some conventional treatments of " transfusion ", " oral western medicine ", " oral Chinese medicine " and the traditional Chinese medical science, though the curative effect that above-mentioned each method is had nothing in common with each other still has many places unsatisfactory.For example transfusion medicine commonly used generally adopts medicines such as " beniol ", " the anti-post enzyme of snake venom ", and its result or curative effect are not remarkable or pay effect obviously, and the infusion model price is higher simultaneously, and must possess the transfusion condition, so the patient accepts to be subjected to certain limitation; And for example oral western medicine mode medicine commonly used is " refined companion's sheet ", " vincamine tablet ", " Thebe woods " etc., its result or be some medicine effect still uncertainly, or must under electrocardiographic monitoring, take for some medicine, while Western medicine price general charged costliness, the patient takes for a long time and can cause heavier financial burden; Oral Chinese medicine is as " restorative bolus ", " DAHUOLUO DAN ", " Rhizoma Gastrodiae Pilulae " etc. for another example, then has curative effect also problem of ultra-high price slowly; Other for another example some conventional therapy means of the traditional Chinese medical science be difficult to obtain unified clinical effectiveness as Yin Shizhi person's maneuvers such as " acupuncture ", " massage " are different.

The object of the present invention is to provide a kind of Chinese medicine of special treatment cerebral infarction sequela, it is low that it has a cost than above-mentioned each method of each medicine, price is low, and obvious results characteristics, the bearing of economic capability that helps the patient also is applicable to disease that brain atrophy, hyperlipidemia, high blood viscosity and all thrombosis cause simultaneously, is the new medicine that a kind of utmost point has DEVELOPMENT PROSPECT.

Technical scheme of the present invention: a kind of Chinese medicine for the treatment of cerebral infarction sequela is characterized in that it is by Radix Angelicae Sinensis 20-25%, Radix Polygoni Multiflori 10-15%, field dobber 10-15%, Radix Achyranthis Bidentatae 15-25%, Fructus Psoraleae 15-20%, Fructus Rubi 10-15% forms, and above-mentioned prescription patent medicine can be pill or oral solutions.

The instructions of taking of the related Chinese medicine of the present invention: be generally every day three times, each potion, be about 20 days a conventional course of treatment, can receive significant curative effect in 120-180 days.

The therapeutic effect and the superiority of the related Chinese medicine of the present invention are: 1, the anaphase of cerebral infarction sequela and convalescent period are interior owing to be subjected to various situations, comprise influences such as emotion, environment, weather, so general medicine is difficult to reach the purpose of healing, this product is reused blood circulation promoting and enriching medicine, evident in efficacy and produce effects is fast, has exempted part patient can not be taken medicines such as Radix Ginseng, the Radix Astragali because of " not mending " worries; 2, blood circulation promoting and blood stasis dispelling, promotion of blood circulation, vessel softening, add the smart marrow of mending, be applicable to diseases such as various diseases that all thrombosis cause and brain atrophy, hyperlipidemia, high blood viscosity, have prevention " apoplexy " simultaneously and take place and recurrent effect that the body defying age is also had certain effect; 3, nontoxic, pair effect; 4, this product is with low cost, and taking convenience has the wide development prospect.

Further specify this medicine below in conjunction with embodiment.

Embodiment: get Radix Angelicae Sinensis 20%, the Radix Polygoni Multiflori 15%, field dobber 15%, Radix Achyranthis Bidentatae 20%, Fructus Psoraleae 15%, Fructus Rubi 15% adopts the medicine pill routine fashion to make honeyed pill, every ball 6-9 gram.

Claims

1, a kind of Chinese medicine for the treatment of cerebral infarction sequela is characterized in that it is by Radix Angelicae Sinensis 10-25%, Radix Polygoni Multiflori 10-15%, field dobber 10-15%, Radix Achyranthis Bidentatae 15-25%, Fructus Psoraleae 15-20%, Fructus Rubi 10-15% is made, and above-mentioned prescription patent medicine can be pill or oral solutions.

2, by the Chinese medicine of the said treatment cerebral infarction sequela of claim 1, the composition that it is characterized in that said honeyed pill is for getting Radix Angelicae Sinensis 20%, the Radix Polygoni Multiflori 15%, field dobber 15%, Radix Achyranthis Bidentatae 20%, Fructus Psoraleae 15%, Fructus Rubi 15%.